Healthcare & Life Sciences
Sigilon Therapeutics
United Stateswww.sigilon.com
Sigilon Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
2015
Founded
1
Investors
About Sigilon Therapeutics
Sigilon Therapeutics is a startup founded in 2015 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Sigilon Therapeutics develops biopharmaceutical therapies that use encapsulated cell technology to provide long-lasting treatment for chronic diseases.
Explore Sigilon Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.